Advancing Personalized Medicine through Vessel-Supported Patient-Established Lung Tumor Organoids: A Microfluidic Approach
ACS Biomaterials Science & Engineering · 08.06.2026 · 12 (6) · 2985-2996
DOI: 10.1021/acsbiomaterials.5c01908 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 28.05.2026. Verfasst von Xiaochen Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States. Hauptthemen laut MEDLINE: Organoids, Precision Medicine, Lung Neoplasms, Antineoplastic Agents. Die Arbeit nennt 71 Literaturangaben.
Abstract (Originalsprache)
In recent years, patient-derived organoid models have become increasingly valuable for studying cancer biology and guiding personalized therapies. Unlike traditional homotypic cell cultures, these three-dimensional organoids closely replicate the structural, genetic, and functional characteristics of primary tumors, making them a more physiologically relevant in vitro model. To further enhance the accuracy and efficiency of tumor modeling, we report a novel approach to expedite preclinical anticancer drug screening using vessel-supported patient-established tumor organoids. Our method involves a standardized and speedy mechanical microsectioning process to produce hundreds to thousands of patient tissue fragments from tumorous surgical discards, enabling a fast formation of the tumor organoids. These established organoids could be further integrated into a bilayer microfluidic vascular-mimic endothelium-interface platform, simulating the tumor microenvironment with dynamic culture. The significance of the endothelium becomes evident during chemotherapy drug screening, as different types of drugs are administered to patients through the system. Under this dynamic condition, the dose-dependent effect on viability is less impactful compared to traditional static conditions. The combination of patient-derived tumor organoids, established through mechanical methods, with a cost-effective microfluidic system holds great promise for personalized medicine. By closely replicating patient-specific drug responses in a dynamic tumor microenvironment, this approach could advance preclinical drug screening, thus potentially improving treatments for patients with lung cancer and beyond.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
- Department of Biological Science, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
- Department of Mechanical Engineering and Mechanics, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
- Precision Medicine Translational Research Center, Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 18015, China.
- School of Engineering, Dali University, Dali 671003, China.
ORCID-Profile: Xiaochen Qin, Yuwen Zhao, Yue Wu, Ratul Paul, Yaling Liu
Zitieren
APA
Qin, X., Zhao, Y., Wu, Y., Efelis, A., Paul, R., Islam, K., Serrano Marquez, C., Liu, Y., & Liu, Y. (2026). Advancing Personalized Medicine through Vessel-Supported Patient-Established Lung Tumor Organoids: A Microfluidic Approach. ACS Biomaterials Science & Engineering, 12(6), 2985-2996. https://doi.org/10.1021/acsbiomaterials.5c01908
Vancouver
Qin X, Zhao Y, Wu Y, Efelis A, Paul R, Islam K, et al. Advancing Personalized Medicine through Vessel-Supported Patient-Established Lung Tumor Organoids: A Microfluidic Approach. ACS Biomaterials Science & Engineering. 2026;12(6):2985-2996. doi:10.1021/acsbiomaterials.5c01908
BibTeX
@article{Qin2026,
author = {Qin, Xiaochen and Zhao, Yuwen and Wu, Yue and Efelis, Alexander and Paul, Ratul and Islam, Khayrul and Serrano Marquez, Cynthia and Liu, Yaling and Liu, Yi},
title = {Advancing Personalized Medicine through Vessel-Supported Patient-Established Lung Tumor Organoids: A Microfluidic Approach},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
volume = {12},
number = {6},
pages = {2985--2996},
doi = {10.1021/acsbiomaterials.5c01908}
}
EUVIMED